Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
03/2012
03/01/2012US20120053163 Steroids as Agonists for FXR
03/01/2012US20120053159 Isotopologues of lenalidomide
03/01/2012US20120053158 Preparation of an acetyl salicylic acid/glutamic acid complex for oral administration
03/01/2012US20120053157 Methods for the treatment or prophylaxis of thrombosis or embolism
03/01/2012US20120053147 Thiazolopyrimidinone derivatives as pi3 kinase inhibitors
03/01/2012US20120053113 MANUFACTURE OF INTER-ALPHA-INHIBITOR (IaIp) FROM PLASMA
03/01/2012US20120052292 Novel medical device coatings
03/01/2012US20120052132 Compositions and methods for treatment of body weight conditions
03/01/2012US20120052130 Gpr 119 modulators
03/01/2012US20120052128 Oral compositions comprising edible oils and vitamins and/or minerals and methods for making oral compositions
03/01/2012US20120052125 Cholesteryl Sulfate-Containing Composition As A Haemostatic
03/01/2012US20120052095 Topical formulation(s) for the treatment of inflammation, skin and mucosal disorders and other diseases thereof
03/01/2012US20120052088 Pneumococcal vaccine and uses thereof
03/01/2012US20120052072 High affinity human antibodies to human il-4 receptor
03/01/2012US20120052070 Compositions and methods of use for binding molecules to dickkopf-1 or dickkopf-4 or both
03/01/2012US20120052067 Activin-actrii antagonists and uses for increasing red blood cell levels
03/01/2012US20120052058 Methods of managing the blood coagulation and pharmaceutical compositions related thereto
03/01/2012US20120052057 method for selecting responders to blockade of integrin receptors
03/01/2012US20120052055 Method of treating thrombocytopenia
03/01/2012US20120052005 Combination therapy to improve drug efficiency
03/01/2012CA2808520A1 Methods for the treatment or prophylaxis of thrombosis or embolism
02/2012
02/29/2012EP2423224A1 Compositions and methods for modulating hemostasis
02/29/2012EP2421877A1 Anionic conjugates of glycosylated bacterial metabolite
02/29/2012EP2421859A1 Thiazole derivatives and their use as p2y12 receptor antagonists
02/29/2012EP2421519A1 Blockers of nmda receptor for the treatment of sickle cell anemia
02/29/2012EP2123649B1 3-pyrrolo-cyclohexylene-2-dihydro-indolinone derivatives and uses thereof
02/29/2012EP1390383B1 Antisense permeation enhancers
02/29/2012EP1311269B1 Method of using diketopiperazines and composition containing them
02/29/2012CN1351656B Human liver progenitors
02/29/2012CN102365293A Nucleic Acids Specifically Binding With Human Factor Vii/Viia And Uses Thereof
02/29/2012CN102363621A Cefminox sodium hexahydrate, preparation method thereof and pharmaceutical composition containing hexahydrate
02/29/2012CN102362982A Thrombus-preventing traditional Chinese medicine preparation used in apoplexy tendency, and preparation method thereof
02/29/2012CN102362978A Chinese medicinal composition having effects of tonifying kidney, replenishing essence, replenishing qi and nourishing blood
02/29/2012CN102362932A Externally applied medicine for treating cattle anthracnose
02/29/2012CN102362929A Chinese medicinal composition and extract for treating cancer ischemia, and preparation method and formulation of Chinese medicinal extract
02/29/2012CN102362922A Medicinal liquor for nourishing blood and retaining youthful looks
02/29/2012CN102362905A Method for preparing capsules for removing stasis and unblocking channels
02/29/2012CN102362892A Oral medicine for treating mumps and preparation method thereof
02/29/2012CN102362874A Leech colon targeted oral preparation and preparation method thereof
02/29/2012CN102362870A Injection for treating iron deficiency anemia and preparation method thereof
02/29/2012CN102106907B Quality control method for rhubarb (traditional Chinese medicine) ethanol-extraction process
02/29/2012CN102068636B Herbal preparation for treating ascitic type liver cancer
02/29/2012CN102028712B Method for preparing enteric capsules by taking leech as raw material
02/29/2012CN101940740B Chinese medicinal preparation for treating anemia
02/29/2012CN101926999B Hemostatic disinfectant and preparation method thereof
02/29/2012CN101785800B Traditional Chinese medicine combination for hepatopathy treatment
02/29/2012CN101679309B Novel pyrimidine compound having dibenzylamine structure, and medicine comprising the compound
02/29/2012CN101657205B Agent for preventing bleeding from cerebral cortical vein
02/29/2012CN101496636B Method for preparing and using functional plant stuffing for thin sheet raw material of paper-making process
02/29/2012CN101297977B Biological adhesive agent and use thereof
02/29/2012CN101273995B Method for preparing magnetic particles modified by afi-tiazin dyes
02/28/2012US8124638 Tricyclic compounds useful as angiotensin II agonists
02/28/2012US8124586 Prevention and reduction of blood loss
02/28/2012US8124378 Murine zcytor17 ligand polynucleotides
02/28/2012US8124078 Method for treating idiopathic thrombocytopenic purpura using monoclonal antibodies
02/23/2012WO2012024161A1 Method of activating regulatory t cells with alpha-2b adrenergic receptor agonists
02/23/2012WO2012022487A1 Substituted cyclic carboxamide and urea derivatives as ligands of the vanilloid receptor
02/23/2012WO2012003554A3 Compositions and methods for removal or destruction of amyloid fibril or amyloid adhesin comprising aggregates
02/23/2012WO2011163533A3 One step removal of selected molecules from body fluid and tissue
02/23/2012WO2011127176A3 Methods for treating or screening for compounds for the treatment of sepsis
02/23/2012WO2011126903A3 Multisubstituted aromatic compounds as inhibitors of thrombin
02/23/2012US20120046441 Combinatorial Synthesis of Libraries of Macrocyclic Compounds Useful in Drug Discovery
02/23/2012US20120046368 Method for purifying 3,4-dihydroxyphenylglycol (dhpg) from plant products
02/23/2012US20120046364 Novel Sulfonic Acid-Containing Thyromimetics, and Methods for Their Use
02/23/2012US20120046348 Oligonucleotide chelate complexes
02/23/2012US20120046335 Solid states of atorvastatin potassium
02/23/2012US20120046330 Pharmaceutical compositions of (r)-1-(2,2-difluorobenzo[d] [1,3]dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl) cyclopropanecarboxamide and administration thereof
02/23/2012US20120046325 Isoxazoline Compounds Having MIF Antagonist Activity
02/23/2012US20120046322 Bioavailable Diacylhydrazine Ligands for Modulating the Expression of Exogenous Genes via an Ecdysone Receptor Complex
02/23/2012US20120046303 Benzimidazole poly(adp ribose)polymerase inhibitors
02/23/2012US20120046300 Quinazoline Derivatives as Angiogenesis Inhibitors
02/23/2012US20120046286 Novel Compounds
02/23/2012US20120046268 Substituted piperidines as Par-1 Antagonists
02/23/2012US20120046241 Dose of ave5026 for the treatment of venous thromboembolism in patients with severe renal impairment
02/23/2012US20120046231 Composition and process for synthesizing polymerized human serum albumin for applications in transfusion medicine
02/23/2012US20120046230 Combination Anticoagulant Therapy With A Compound That Acts As A Factor Xa Inhibitor
02/23/2012US20120046221 Albumin fusion proteins
02/23/2012US20120046219 Melanocortin receptor-specific peptides
02/23/2012US20120045518 Enhancing coagulation or reducing fibrinolysis
02/23/2012US20120045507 Stable soft capsule dosage form for acetylsalicylic acid
02/23/2012US20120045500 Novel dioxo-imidazolidine derivatives, which inhibit the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them
02/23/2012US20120045487 Multiphasic microfibers for spatially guided cell growth
02/23/2012US20120045483 Mannitol and/or Proline for Prevention and Treatment of Ageing Related Symptoms
02/23/2012US20120045452 Mnk KINASE HOMOLOGOUS PROTEINS INVOLVED IN THE REGULATION OF ENERGY HOMEOSTASIS AND ORGANELLE METABOLISM
02/23/2012US20120045451 Mnk KINASE HOMOLOGOUS PROTEINS INVOLVED IN THE REGULATION OF ENERGY HOMEOSTASIS AND ORGANELLE METABOLISM
02/23/2012US20120045444 Treatment for Neoplastic Diseases
02/23/2012US20120045438 Engineered anti-il-13 antibodies, compositions, methods and uses
02/23/2012US20120045435 Compositions and methods to inhibit stem cell and progenitor cell binding to lymphoid tissue and for regenerating germinal centers in lymphatic tissues
02/23/2012US20120045430 Dendrimer-like modular delivery vector
02/23/2012US20120045426 Compositions for reducing the deleterious effects of stress and aging
02/23/2012US20120045425 Delta 4, 5 glycuronidase compositions and methods related thereto
02/23/2012DE102010034699A1 Pyrimidinderivate Pyrimidine derivatives
02/23/2012CA2855690A1 Oligonucleotide chelate complexes
02/23/2012CA2808307A1 Method of activating regulatory t cells with alpha-2b adrenergic receptor agonists
02/23/2012CA2806634A1 Substituted cyclic carboxamide and urea derivatives as ligands of the vanilloid receptor
02/22/2012EP2420572A1 Monoclonal antibody capable of binding to specific discontinuous epitope occurring in ad1 region of human cytomegalovirus gb glycoprotein, and antigen-binding fragment thereof
02/22/2012EP2420563A1 Method for denucleating nucleated erythrocyte, and denucleation inducer
02/22/2012EP2420502A1 Fused pyrrolopyridine derivative
02/22/2012EP2420243A1 Compositions obtainable from bred beetroot juice to promote iron absorption and blood forming
02/22/2012EP2419403A1 Vitamin d receptor agonists and uses thereof
1 ... 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 ... 671